This trial detected CRP, IL-6, and TNF-α to assess the inflammatory response in DN patients and they were lower in the experimental group than in the control group, supporting the efficacy of targeted nursing and nutritional support in controlling inflammation in DN patients. The gene discussed is IL6; the disease is liver dysplastic nodule.